AIDS Dementia Complex (ADC) is brain and nerve injury that happens in some people living with HIV, usually when the immune system has been weak for a long time. The virus does not directly eat brain cells. Instead, HIV enters the brain early in infection and “lives” mainly inside immune cells there (macrophages and microglia). These cells release chemicals that cause long-lasting inflammation. That inflammation harms the white matter “wires” that connect different brain areas, and it stresses the deep parts of the brain that control speed, attention, and movement (especially the basal ganglia).

AIDS dementia complex (ADC) is the older name for a brain condition caused directly by HIV. Today, doctors group it within HIV-associated neurocognitive disorders (HAND). HAND is a spectrum with three levels: asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), and the most severe form, HIV-associated dementia (HAD)—which is essentially the modern term for ADC. In simple words, the virus and the body’s immune reaction injure brain cells and their connections. Thinking, attention, memory, mood, and movement may slow down. This is more likely when HIV is not treated, when the immune system is weak (low CD4), or when there are other brain problems at the same time. Doctors diagnose HAND by testing at least two thinking skills and by checking how symptoms affect daily life; the Frascati criteria are the research standard for this staging. PMC+2PMC+2

How does it happen?

HIV can enter the brain early in infection. It rides inside immune cells, crosses the blood-brain barrier, and then sets off long-lasting inflammation. Support cells in the brain (microglia and astrocytes) become activated. They release chemicals that damage nerve cell connections (synapses). Over time this can cause loss of brain volume and white-matter changes that slow thinking and movement. Even on treatment, some people still show signs of low-level immune activation or “legacy” injury. Modern brain scans often show diffuse brain shrinkage and white-matter signal changes; specialized scans (MR spectroscopy and diffusion MRI) can show chemical and fiber-track changes linked to thinking problems. Nature+2Oxford Academic+2

Because of this, ADC is called a subcortical dementia. It shows up first as slowed thinking, poor attention, and slowed movements rather than loss of speech or understanding. In modern care, strong HIV treatment (antiretroviral therapy, or ART) has reduced severe dementia, but milder thinking and movement problems still happen in some people. Doctors now group all HIV-related thinking problems under the umbrella HIV-Associated Neurocognitive Disorders (HAND), and ADC is the older name for the severe end of this spectrum.

Other names

• HIV-associated dementia (HAD)

• HIV encephalopathy

• AIDS dementia complex (older term)

• HIV cognitive/motor complex

• Subcortical dementia due to HIV

• Part of HIV-associated neurocognitive disorders (HAND)

All of these point to similar problems: thinking slows down, movements slow down, and daily function is affected because HIV-related inflammation injures brain networks.

Types

Doctors usually use the HAND scale, which sorts problems by severity and impact on daily life:

1. Asymptomatic Neurocognitive Impairment (ANI)
   On testing, the person is slower or less accurate than expected in several thinking areas. Daily work and personal life are not clearly affected. Many people do not notice symptoms, but formal tests can find them.

2. Mild Neurocognitive Disorder (MND)
   Thinking and movement are slower or less flexible than normal. The person notices problems (for example, more effort to plan, organize, or keep attention). Daily life is affected, but the person can still live independently with some adjustments.

3. HIV-Associated Dementia (HAD) — often what older texts called ADC
   Slowed thinking, poor attention, memory problems, and movement changes are strong and clearly limit daily life (work, money management, medication schedules, travel, or self-care). Mood and behavior may also change (apathy, irritability).

Children living with HIV can have a pediatric form (HIV encephalopathy), which mainly shows developmental delay, poor school performance, and motor problems.

---

Causes

Think of “causes” here as the main drivers and amplifiers that make HIV-related brain injury more likely or more severe.

1. Direct HIV effect in the brain
   HIV enters the brain early and infects immune cells there. Viral proteins and inflammatory chemicals harm connections between nerve cells (synapses) and damage white-matter tracts.

2. Chronic brain inflammation
   Microglia and macrophages stay activated for years. This “always-on” state hurts nearby neurons and myelin (the insulation around brain wiring).

3. Very low CD4 cell count
   A CD4 count below ~200 cells/µL means weak immune defense. With less control of HIV, brain inflammation and injury rise.

4. High HIV viral load
   More virus in blood (and sometimes in spinal fluid) correlates with more brain inflammation and worse cognitive function.

5. CNS viral “escape”
   Sometimes the virus is suppressed in the blood but still replicates in the cerebrospinal fluid (CSF). This local activity can drive brain symptoms even when routine blood tests look good.

6. Delayed start of antiretroviral therapy (ART)
   Years without ART allow steady injury to build up. Starting late may stop new damage but cannot fully reverse old damage.

7. Poor adherence to ART
   Missing many doses lets HIV rebound, which raises inflammation and risk of neurocognitive decline.

8. Antiretroviral penetration into the brain
   Some ART drugs enter the brain better than others. Regimens with poor CNS penetration may leave brain virus less controlled (do not change medicines without your clinician’s advice).

9. Aging
   Normal age-related brain changes plus HIV-related inflammation can add up, making impairment more likely after midlife.

10. Vascular risk factors (high blood pressure, diabetes, high cholesterol, smoking)
    These damage brain blood vessels and white matter, which worsens the subcortical pattern of slowing and poor attention.

11. Hepatitis C coinfection
    HCV can also affect the brain and liver. Combined inflammation and metabolic stress may lower cognitive reserve.

12. Syphilis and neurosyphilis
    Syphilis can infect the nervous system and directly cause cognitive and mood changes, compounding HIV effects.

13. Opportunistic CNS infections (e.g., cryptococcal meningitis, CMV encephalitis, toxoplasmosis)
    These infections injure brain tissue and can leave long-term cognitive and motor problems even after treatment.

14. Progressive multifocal leukoencephalopathy (PML) from JC virus
    PML directly attacks myelin. It is not the same as ADC but can coexist or mimic it, worsening function.

15. Substance use (methamphetamine, cocaine, heavy alcohol)
    These substances are neurotoxic and speed up memory and attention problems.

16. Depression and severe stress
    Mood disorders reduce attention and processing speed and can mask or worsen true cognitive impairment.

17. Sleep disorders (sleep apnea, chronic insomnia)
    Poor sleep quality or oxygen dips harm attention, memory, and executive function.

18. Vitamin deficiencies (especially B12, folate)
    These reduce myelin health and can mimic or magnify subcortical slowing.

19. Anemia and chronic inflammation
    Lower oxygen delivery and systemic inflammation reduce brain energy and repair capacity.

20. Genetic susceptibility (for example, APOE-ε4)
    Some people have genes that lower resilience to inflammatory and vascular injury, increasing risk of impairment.

---

Symptoms and signs

1. Slowed thinking
   Tasks take longer. It is harder to keep track of several ideas at once.

2. Poor attention
   The mind drifts. It is tough to stay on a task or follow a long conversation.

3. Problems with executive function
   Planning, organizing, switching between tasks, and solving new problems become hard.

4. Memory problems (especially new learning)
   Remembering recent events or instructions is difficult, but older memories may be fine.

5. Psychomotor slowing
   Hands and feet move more slowly; fine finger work feels clumsy.

6. Unsteady walk (gait changes)
   The person may shuffle, walk more slowly, or feel off-balance.

7. Poor coordination
   Buttoning shirts, writing neatly, or using tools is harder.

8. Speech changes
   Speech may be soft, slow, or less fluent, but words are still understood.

9. Apathy (loss of drive)
   Less interest in work, hobbies, and social life. This is different from sadness.

10. Irritability or mood swings
    Anger or frustration comes quickly. Small problems feel bigger.

11. Depression or anxiety
    Low mood, worry, and poor sleep often live together with cognitive symptoms.

12. Slowed reading and comprehension
    It takes longer to read and to understand long sentences or instructions.

13. Difficulty managing money and medicines
    Bills, budgets, and pill schedules become confusing; mistakes happen.

14. Work decline
    Tasks that were easy now require more time, more breaks, or extra help.

15. Safety lapses
    Missed stove, lost keys, wrong bus, or getting lost on familiar routes.

---

Diagnostic tests

Physical examination

1. General neurological exam
   The clinician checks strength, reflexes, sensation, eye movements, coordination, and walking. Purpose: to see the global pattern and to look for signs that suggest other diseases (stroke, multiple sclerosis, neuropathy). In ADC, findings often show slowed movements and mild coordination problems without clear one-sided weakness.

2. Gait and balance assessment
   Timed walk, heel-toe walking, and standing with feet together. Purpose: to detect subcortical motor slowing and postural instability that fit ADC’s “motor” part.

3. Hand tapping and rapid alternating movements
   You tap the index finger or flip the hand palm-up/palm-down quickly. Purpose: a quick screen for psychomotor slowing typical of subcortical problems.

4. Functional assessment of daily living
   Questions about cooking, shopping, transportation, work tasks, and medication management. Purpose: to grade severity (ANI vs MND vs HAD) based on real-world impact.

5. Mood and sleep screen
   Brief questions for depression, anxiety, and sleep quality. Purpose: to find treatable conditions that imitate or worsen cognitive symptoms.

Manual bedside cognitive tests

6. HIV Dementia Scale (HDS) or International HIV Dementia Scale (IHDS)
   Short paper-and-pencil tools focused on psychomotor speed, memory recall, and motor tasks. Purpose: quick screening tailored to HIV-related patterns.

7. Montreal Cognitive Assessment (MoCA)
   A 10-minute test of attention, memory, language, visuospatial skills, and executive function. Purpose: broader screen that is sensitive to mild impairment.

8. Trail Making Tests (A and B)
   You connect numbers (A) and numbers/letters (B) as fast as possible. Purpose: measures processing speed and mental flexibility, which are commonly slowed in ADC.

9. Digit Symbol Substitution or Coding tasks
   Match symbols to numbers under time pressure. Purpose: detects slowed processing speed, the core feature of subcortical dementia.

Laboratory and pathological tests

10. HIV viral load (plasma)
    Measures the amount of HIV in blood. Purpose: higher levels suggest poor control and a higher risk of neurocognitive problems.

11. CD4 T-cell count
    Checks immune strength. Purpose: low counts (especially <200) mean higher risk of ADC and of brain infections that mimic it.

12. Comprehensive metabolic and vitamin panel
    Includes B12, folate, thyroid (TSH), liver and kidney tests. Purpose: finds reversible causes of cognitive slowing like B12 deficiency or thyroid disease.

13. Syphilis serology (RPR/VDRL with confirmatory test)
    Purpose: syphilis can injure the nervous system (neurosyphilis) and must be treated if present.

14. Hepatitis screening (HBV, HCV)
    Purpose: coinfections add systemic inflammation and can worsen cognition.

15. Cerebrospinal fluid (CSF) analysis via lumbar puncture
    Looks at cells, protein, glucose, and may include CSF HIV viral load. Purpose: detects CNS infections, inflammation, and “CNS viral escape,” which can guide ART changes.

16. CSF PCR tests for viruses (JC virus, CMV, HSV, VZV) and cryptococcal antigen
    Purpose: rule out opportunistic infections like PML, CMV encephalitis, or cryptococcal meningitis that can mimic or add to ADC.

Electrodiagnostic and neurophysiologic tests

17. Electroencephalography (EEG)
    Records brain electrical activity. Purpose: in ADC, EEG often shows generalized slowing (a nonspecific sign of diffuse brain dysfunction) and helps rule out seizures or other causes.

18. Event-related potentials (P300) or other evoked potentials (when available)
    Measures the brain’s timing response to stimuli. Purpose: can show delayed processing speed consistent with subcortical dysfunction.

Imaging tests

19. MRI brain with FLAIR and diffusion sequences
    The key imaging test. Purpose: often shows diffuse or patchy white-matter hyperintensities, mild brain atrophy, and sometimes basal ganglia changes—all patterns that fit chronic inflammation and myelin injury.

20. Contrast MRI or CT (when MRI is not available)
    Purpose: looks for mass lesions (like toxoplasmosis), hydrocephalus, strokes, or other structural problems. CT is less sensitive for white-matter disease but is useful when MRI cannot be done.

Non-pharmacological treatments (therapies & others)

1. Start and stick with ART (this is the single most important “non-pill” behavior—daily adherence). Counseling, pillboxes, and digital reminders truly help. clinicalinfo.hiv.gov
   Purpose: suppress HIV to protect brain. Mechanism: lowers viral load in blood/CSF and inflammation.

2. Cognitive rehabilitation (goal-oriented memory/attention training, compensatory strategies like calendars and checklists). Small studies in HIV suggest benefit. SAGE Journals

3. Aerobic exercise (walking, cycling) most days of the week; improves attention, mood, and brain blood flow. PMC

4. Strength and balance training (sit-to-stand, heel-to-toe, tai chi) to reduce fall risk from gait slowing. Verywell Health

5. Sleep hygiene (consistent schedule, dark room, no screens late; test/treat sleep apnea if suspected) to improve concentration.

6. Treat depression and anxiety with therapy (CBT, problem-solving therapy, group support). Improves function and quality of life. American Psychological Association

7. Substance-use treatment (brief counseling, referrals, harm-reduction) because alcohol and stimulants worsen cognition and adherence. PMC

8. Vision and hearing care (glasses, hearing aids) to reduce cognitive load during daily tasks.

9. Vascular risk control with lifestyle (BP, sugar, lipids, smoking cessation) to protect small vessels and white matter. Oxford Academic

10. Nutrition pattern with regular meals and Mediterranean-style emphasis (vegetables, legumes, whole grains, fish) to support brain health.

11. Occupational therapy for home-safety setup, medication management, and energy-saving routines.

12. Caregiver education to use simple language, single-step instructions, and structured routines.

13. Mindfulness/relaxation (brief daily practice) for stress and attention anchoring.

14. Social connection (clubs, faith groups, phone/video check-ins) to lower isolation and cognitive decline risk. PMC

15. Falls prevention (home hazard check, proper footwear, nightlights). ACL Administration for Community Living

16. Adherence support programs/peer support if available at clinic or community groups. ResearchGate

17. Routine vaccinations (flu, COVID-19, pneumococcal, shingles as appropriate) to avoid infections that can worsen cognition.

18. Treat pain and neuropathy with non-drug methods first (heat, pacing, physical therapy) to reduce sedating medications.

19. Work/benefits counseling to adjust duties, apply for supports, and prevent financial stress that worsens health.

20. Regular follow-up with HIV and neurology/mental health teams—early changes can then be handled quickly.

---

Drug treatments

Important safety note: These are examples and typical adult doses used in practice; exact choices depend on drug resistance, co-morbidities, and interactions. Always follow up-to-date national/NIH or IAS-USA HIV guidelines and check interactions (Liverpool HIV Interactions). clinicalinfo.hiv.gov+1

First-line antiretroviral backbones and anchors (core of treatment):

1. Dolutegravir + tenofovir (TAF or TDF) + emtricitabine
   Class: integrase inhibitor + 2 NRTIs. Dose/time: dolutegravir 50 mg once daily (some cases twice daily), plus standard FTC/TAF (200/25 mg) or FTC/TDF (200/300 mg) daily. Purpose: rapid, durable viral suppression. Mechanism: blocks integrase; NRTIs block reverse transcription. Side effects: insomnia, headache; TDF may affect kidneys/bone; TAF gentler on kidneys. Check interactions. clinicalinfo.hiv.gov

2. Bictegravir/TAF/FTC (single tablet)
   Class: INSTI + 2 NRTIs. Dose: one tablet daily. Purpose: first-line ease and potency. Mechanism: as above. Side effects: GI upset, rare mood/sleep issues; few interactions. SSRIs like sertraline generally safe with bictegravir. hiv-druginteractions.org

3. Dolutegravir/abacavir/lamivudine (for HLA-B*57:01–negative individuals)
   Class: INSTI + 2 NRTIs. Dose: one tablet daily. Purpose: potent option when TAF/TDF unsuitable. Side effects: abacavir hypersensitivity if HLA-B*57:01 positive; MI risk debated. clinicalinfo.hiv.gov

4. Darunavir/cobicistat + TAF/FTC
   Class: boosted protease inhibitor + 2 NRTIs. Dose: once daily with food. Purpose: high barrier to resistance. Mechanism: blocks viral protease. Side effects: GI upset, lipids; many interactions (e.g., with antidepressants). Monitor when combined with sertraline. hiv-druginteractions.org

5. Doravirine + 2 NRTIs
   Class: NNRTI. Dose: 100 mg daily. Purpose: alternative for selected patients. Side effects: nausea, dizziness; fewer CNS effects than older NNRTIs. clinicalinfo.hiv.gov

6. Rilpivirine + cabotegravir (long-acting injections) after oral lead-in and confirmed suppression
   Class: INSTI + NNRTI (LA). Dose: monthly or every 2 months. Purpose: for people who struggle with daily pills but can attend injections. Side effects: injection-site pain; rilpivirine needs acid for absorption during oral phase. clinicalinfo.hiv.gov

Additional or special-situation ARVs (selected examples):

7. Maraviroc (CCR5 antagonist—needs CCR5-tropic virus)
   Dose: typically 300 mg twice daily (varies with interacting drugs). Purpose: sometimes used in intensification when cognitive issues persist; mixed evidence. Mechanism: blocks CCR5 co-receptor. Side effects: liver issues, dizziness; many interactions. Lippincott Journals+1

8. Zidovudine (AZT)
   Class: NRTI. Dose: 300 mg twice daily. Purpose: sometimes added when CSF viral escape is suspected; historical CNS penetration. Side effects: anemia, GI upset. (Use is individualized.) PMC

9. Lenacapavir (capsid inhibitor, long-acting; for heavily treatment-experienced)
   Dose: loading then subcutaneous every 6 months with other ARVs. Purpose: salvage regimens; not specific for HAND. Side effects: injection-site reactions. Evidence on cognition is lacking. NATAP

Medications for common co-symptoms (used alongside ART):

10. Sertraline (SSRI) for depression/apathy
    Dose: 25–200 mg daily. Purpose: treat mood symptoms that worsen cognition and function. Mechanism: increases brain serotonin. Side effects: GI upset, sleep change; check interactions—usually safe with TAF/FTC and bictegravir; monitor with ritonavir/cobicistat. hiv-druginteractions.org+2hiv-druginteractions.org+2

11. Citalopram/Escitalopram (SSRIs)
    Dose: citalopram 10–40 mg; escitalopram 5–20 mg daily. Purpose: alternatives with relatively low interaction risk. Side effects: QT prolongation at higher citalopram doses; check interactions. PMC

12. Bupropion for depression/fatigue (avoid with seizure risk)
    Dose: 150–300 mg daily (SR/XL). Purpose: activating antidepressant. Mechanism: norepinephrine/dopamine reuptake inhibition. Side effects: insomnia, anxiety; interactions with some PIs/NNRTIs.

13. Methylphenidate (low dose) for apathy/psychomotor slowing in selected patients
    Dose: start 2.5–5 mg morning; titrate carefully. Purpose: improve speed/attention. Mechanism: dopaminergic stimulant. Side effects: BP/HR rise, anxiety; avoid in substance-use disorder.

14. Modafinil for daytime sleepiness/fatigue
    Dose: 100–200 mg in the morning. Purpose: promote wakefulness. Side effects: headache, anxiety; interactions via CYP. (Use cautiously.)

15. Trazodone for insomnia
    Dose: 25–100 mg at night. Purpose: improve sleep. Side effects: sedation, orthostasis; check interactions.

16. Quetiapine (very low dose) only for distressing psychosis/agitation
    Dose: 12.5–25 mg at night; titrate. Purpose: behavioral control in severe cases. Side effects: sedation, metabolic effects; major interactions with boosted PIs—dose adjustments needed.

17. Pain/neuropathy agents (gabapentin/pregabalin, duloxetine) when peripheral pain worsens function. Check interactions.

18. Memantine (NMDA blocker) has not shown clear cognitive benefit in RCTs for HAND; can be considered case-by-case but evidence is negative. Dose: if used, 10 mg twice daily. Side effects: dizziness, headache. PubMed

19. Selegiline (MAO-B inhibitor) likewise did not show functional cognitive benefit in phase II. Not routine. PubMed

20. Manage OI prophylaxis when CD4 is low (e.g., TMP-SMX for toxoplasma if CD4 <100 and IgG positive; cryptococcal antigen screening at low CD4 in high-burden settings). This prevents brain infections that mimic or worsen dementia. BHIVA+1

---

Dietary molecular supplements

(Use only after discussion with the HIV team; evidence in HAND is limited—these are supportive, not cures.)

1. Vitamin B12 (e.g., 500–1000 mcg/day oral or injections if deficient). Function: corrects deficiency that can mimic dementia. Mechanism: restores myelin/DNA synthesis.

2. Folate (0.4–1 mg/day when low). Function: supports methylation and blood cell health.

3. Thiamine (B1) (50–100 mg/day if poor nutrition or alcohol use). Function: prevents Wernicke-like cognitive issues.

4. Vitamin D3 (1000–2000 IU/day if low). Function: bone and immune support; mixed cognitive evidence.

5. Omega-3 fatty acids (EPA/DHA) (1–2 g/day). Function: anti-inflammatory; small cognitive and mood benefits in general populations; HIV-specific data are limited.

6. Magnesium glycinate (100–200 mg at night). Function: sleep quality and anxiety; indirect cognitive benefit.

7. N-acetylcysteine (NAC) (600–1200 mg/day). Function: antioxidant replenishing glutathione; studied for oxidative stress in HIV.

8. Coenzyme Q10 (100–200 mg/day). Function: mitochondrial support; limited data.

9. Multivitamin with minerals to cover dietary gaps.

10. Probiotics/fiber supplement for gut health, which may indirectly affect inflammation.

(Proof for supplements in HAND is modest; treat deficiencies first. Always check for drug interactions with ART and other meds.) HIV Curriculum

---

Regenerative / stem-cell” drugs

There are no approved stem-cell or regenerative drugs for HAND/ADC. Below are research directions or narrow indications—not routine care. I list them to clarify the landscape.

1. Hematopoietic stem-cell transplant with CCR5-Δ32 donor—this has cured HIV in rare cancer patients but is not a treatment for dementia; it is risky and done for leukemia/lymphoma, not for HAND. The Lancet

2. Broadly neutralizing antibodies (bNAbs)—IV antibodies that can suppress HIV in trials; still investigational for long-term therapy and not shown to reverse HAND. Nature+1

3. Interleukin-7 (IL-7)—immune-restoring cytokine in trials that can raise T-cell counts; not a HAND therapy and not standard HIV care. ClinicalTrials.gov

4. Maraviroc “neuro-inflammation” strategy—CCR5 blockade explored for HAND; mixed trial results; consider only in expert hands when indicated. Lippincott Journals

5. Lenacapavir long-acting capsid inhibitor—useful for resistant HIV; no evidence it repairs cognition. NATAP

6. Adjunct neuroprotectives (e.g., memantine, selegiline, lithium)—tested but no proven cognitive benefit in controlled HAND trials; not regenerative. PubMed+1

---

Surgeries

There is no surgery for ADC/HAD itself. Procedures occur only when we are diagnosing or treating other brain problems:

1. Lumbar puncture (needle in lower back to test CSF)—diagnostic, not surgical treatment; rules out infections and checks CSF HIV RNA. Lippincott Journals

2. Brain biopsy—rare, only when mass lesions or lymphoma are suspected and diagnosis is uncertain.

3. Ommaya reservoir—rarely placed for intrathecal chemo when CNS lymphoma is diagnosed (not for ADC itself).

4. Ventriculoperitoneal shunt—only if the person also has normal-pressure hydrocephalus causing gait/cognitive issues.

5. Sinus/ear/other infection surgeries—only when severe infections are the true cause of symptoms.

---

Prevention strategies

1. Test and treat HIV early—starting ART promptly is the strongest prevention of HAND. clinicalinfo.hiv.gov

2. Adhere to ART daily—use reminders, pillboxes, or long-acting options if appropriate. clinicalinfo.hiv.gov

3. Regular HIV clinic visits with viral load/CD4 checks—catch problems before they harm the brain.

4. Control blood pressure, diabetes, and cholesterol—protect small brain vessels. Oxford Academic

5. Avoid or limit alcohol and drugs—they worsen cognition and adherence. PMC

6. Sleep well and treat sleep apnea—protect attention and memory.

7. Stay physically active—aerobic + strength + balance lowers cognitive decline and falls. Verywell Health

8. Vaccinations and OI prevention when CD4 is low (toxoplasma, cryptococcal screening in high-burden settings). BHIVA+1

9. Treat depression and anxiety—improves thinking and adherence. American Psychological Association

10. Keep socially engaged and mentally stimulated—supports cognitive reserve. PMC

---

When to see doctors urgently

Seek help now if there is sudden weakness, numbness, severe headache, fever with confusion, new seizures, visual loss, or rapidly worsening walking or bladder control—these suggest stroke or brain infection, not just ADC. See your HIV team soon if memory, attention, or mood changes last more than two weeks, if you fall, if you miss pills often, or if family notices personality change. Doctors may check MRI and spinal fluid to rule out infections and CSF viral escape when symptoms do not match blood tests. PMC+1

---

What to eat and what to avoid

1. Base meals on vegetables, legumes, whole grains, and fruits.

2. Eat fish or legumes several times per week for protein and omega-3s.

3. Choose olive/vegetable oils and nuts over saturated fats.

4. Regular breakfast and steady meals—brain likes even energy.

5. Stay hydrated; limit sugary drinks.

6. Limit alcohol; avoid binge drinking. PMC

7. If underweight or nutrient-deficient, add fortified foods or a multivitamin; treat B12 or vitamin D deficiencies when present.

8. If overweight or diabetic, reduce refined carbs and added sugars.

9. Avoid grapefruit and St. John’s wort unless your HIV clinician confirms they are safe with your ART—drug interactions matter. HIV Curriculum

10. Food is not a cure—it supports the brain along with ART and therapies.

---

Frequently asked questions

1) Is AIDS dementia complex the same as HIV-associated dementia?
Yes. ADC is the older term; HIV-associated dementia (HAD) is the modern severe end of the HAND spectrum. PMC

2) Can this get better with treatment?
Yes. Many people improve in thinking speed and daily function after consistent ART and supportive care, especially if treated early. Oxford Academic

3) What is the best ART for the brain?
Any fully suppressive, guideline-recommended regimen is best. The old idea of picking drugs only by “CNS penetration” score has not shown clear benefit and is not recommended as a rule. WebMD

4) What is CSF viral escape?
It means the virus is detectable in spinal fluid while blood appears suppressed. Doctors may adjust ART after checking resistance. This is guided by expert opinion and case evidence; evaluation is important when symptoms persist. MDPI

5) Which scans show this condition?
MRI often shows brain atrophy and symmetric white-matter changes; advanced scans and MR spectroscopy can add detail. Radiopaedia

6) Do dementia drugs like memantine help?
In trials for HAND they were safe but did not show clear cognitive benefit; they are not standard treatment. PubMed

7) Can long-acting injections replace pills?
Some people can switch to cabotegravir/rilpivirine injections after achieving suppression. Your clinician will assess eligibility. clinicalinfo.hiv.gov

8) What about stem-cell cures?
A few people with cancer were cured of HIV after CCR5-Δ32 transplants, but this is not a treatment for HAND and carries major risks. The Lancet

9) Does exercise really help the brain?
Yes. Structured balance, gait, and aerobic programs reduce falls and support cognitive health. Verywell Health

10) Which antidepressants are safe with ART?
SSRIs like sertraline or escitalopram are common choices; always check for interactions, especially with boosted protease inhibitors. hiv-druginteractions.org+1

11) Can vitamins cure this?
No. Supplements help only when there is a deficiency or a specific goal (e.g., sleep), and they never replace ART. HIV Curriculum

12) How do doctors confirm the diagnosis?
By cognitive testing across domains, functional assessment, and ruling out infections or other causes with blood tests, MRI, and sometimes spinal fluid. PMC

13) Is this the same as Alzheimer’s disease?
No. The pattern is more subcortical (speed/attention/executive) with gait changes; however, older adults with HIV can also develop Alzheimer’s separately. Nature

14) If my blood viral load is undetectable, can I still have symptoms?
Yes. Symptoms can persist due to legacy injury, other conditions, or—less commonly—CSF viral escape. That’s why thorough evaluation matters. Oxford Academic+1

15) What is the single most important step I can take today?
Take ART every day and see your HIV team about new cognitive or mood changes. Early action prevents long-term problems. clinicalinfo.hiv.gov

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 11, 2025.